Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIX NASDAQ:INBS NASDAQ:LYRA NASDAQ:MHUA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$1.42-0.7%$1.55$1.14▼$42.40$3.98M-2.99489,174 shs79,778 shsINBSIntelligent Bio Solutions$1.90+9.8%$1.60$1.00▼$3.00$11.95M4.6567,059 shs808,534 shsLYRALyra Therapeutics$8.48-2.6%$9.99$3.81▼$37.50$11.54M0.24192,235 shs25,955 shsMHUAMeihua International Medical Technologies$0.44-1.6%$0.42$0.25▼$1.47$14.17M0.79687,558 shs62,630 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical-0.70%-2.07%+9.23%-19.77%-94.86%INBSIntelligent Bio Solutions+9.83%+11.11%-0.52%+58.33%-1.55%LYRALyra Therapeutics-2.64%-8.32%-25.22%+84.35%-44.39%MHUAMeihua International Medical Technologies-1.55%+6.66%+28.29%+41.05%-51.86%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMIXAutonomix Medical2.8217 of 5 stars3.52.00.00.02.61.71.3INBSIntelligent Bio Solutions0.8266 of 5 stars0.03.00.00.02.60.01.3LYRALyra Therapeutics2.6742 of 5 stars3.22.00.00.02.42.51.3MHUAMeihua International Medical Technologies1.3191 of 5 stars0.03.00.00.03.81.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 3.00Buy$16.501,061.97% UpsideINBSIntelligent Bio Solutions 0.00N/AN/AN/ALYRALyra Therapeutics 2.33Hold$100.001,079.25% UpsideMHUAMeihua International Medical Technologies 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest AMIX, MHUA, LYRA, and INBS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/29/2025AMIXAutonomix MedicalMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$5.00(Data available from 7/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$3.29 per shareN/AINBSIntelligent Bio Solutions$3.11M4.22N/AN/A$2.37 per share0.80LYRALyra Therapeutics$1.53M7.37N/AN/A$8.86 per share0.96MHUAMeihua International Medical Technologies$96.90M0.14$0.45 per share0.98$6.34 per share0.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$11.41M-$7.47N/AN/AN/AN/A-174.70%-133.35%N/AINBSIntelligent Bio Solutions-$10.16MN/A0.005.43N/A-319.85%-176.55%-93.89%9/17/2025 (Estimated)LYRALyra Therapeutics-$93.43M-$60.50N/AN/AN/A-6,711.39%-295.52%-66.95%8/13/2025 (Estimated)MHUAMeihua International Medical Technologies$10.84MN/A0.00∞N/AN/AN/AN/AN/ALatest AMIX, MHUA, LYRA, and INBS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/29/2025Q4 2025AMIXAutonomix MedicalN/A-$0.74N/A-$0.74N/AN/A5/6/2025Q1 2025LYRALyra Therapeutics-$7.50-$6.00+$1.50-$0.13$0.16 million$0.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/AINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/ALYRALyra TherapeuticsN/AN/AN/AN/AN/AMHUAMeihua International Medical TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A5.635.63INBSIntelligent Bio SolutionsN/A1.120.97LYRALyra TherapeuticsN/A2.962.96MHUAMeihua International Medical TechnologiesN/A5.265.21Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%INBSIntelligent Bio Solutions32.97%LYRALyra Therapeutics95.62%MHUAMeihua International Medical Technologies1.17%Insider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical32.40%INBSIntelligent Bio Solutions0.28%LYRALyra Therapeutics3.25%MHUAMeihua International Medical Technologies66.56%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical12.78 million1.88 millionN/AINBSIntelligent Bio Solutions106.91 million6.89 millionNot OptionableLYRALyra Therapeutics501.33 million1.28 millionOptionableMHUAMeihua International Medical Technologies62031.90 million10.67 millionNot OptionableAMIX, MHUA, LYRA, and INBS HeadlinesRecent News About These CompaniesMeihua International Gains Nasdaq Capital Market Approval Amid Compliance EffortsJune 6, 2025 | tipranks.comMeihua International Medical Technologies Full Year 2024 Earnings: EPS: US$0.40 (vs US$0.49 in FY 2023)April 27, 2025 | finance.yahoo.comMeihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year ResultsApril 25, 2025 | prnewswire.comMeihua International Halts Convertible Note Sales, Amends Securities AgreementJanuary 3, 2025 | tipranks.comMeihua International Medical Technologies (NASDAQ:MHUA) Is Reinvesting At Lower Rates Of ReturnDecember 23, 2024 | uk.finance.yahoo.comRemote medical interpreting is a double-edged sword in healthcare communication, researchers findNovember 6, 2024 | sciencedaily.comSDigital Medical and Artificial Intelligence Innovation Forum Held in BeijingOctober 31, 2024 | markets.businessinsider.comGlobal medical technology firm shifts some of its California manufacturing to MexicoOctober 22, 2024 | msn.comMeihua Intl Medical Techs (NASDAQ:MHUA) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comMeihua International Medical Technologies Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price RequirementOctober 7, 2024 | prnewswire.comMeihua Intl Medical Techs (NASDAQ:MHUA) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comMeihua International Medical Technologies First Half 2024 Earnings: EPS: US$0.19 (vs US$0.29 in 1H 2023)September 25, 2024 | finance.yahoo.comMeihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial ResultsSeptember 20, 2024 | prnewswire.comFrost & Sullivan grants the Global Medical Imaging Foundation Model Innovation Award to Hangzhou Diagens Biotechnology Co.,Ltd.September 18, 2024 | digitimes.comDMIT xPRO Launches the Medical Technology Program for Global Leaders in Collaboration with EmeritusSeptember 18, 2024 | tmcnet.comICMR signs agreements with Industry, Academic Partners to Advance First-in-Human Phase 1 Clinical TrialsSeptember 15, 2024 | malaysiasun.comMMeihua International Medical Technologies Co., Ltd. to Present at LIVE!August 26, 2024 | prnewswire.comEpica International Inc. Partners With M.A.R.C. Institute, Pioneering Medical EducationAugust 15, 2024 | joplinglobe.comJMeihua International Medical Technologies Co Ltd (NASDAQ:MHUA) Stock Price Slipped -9.80% to $0.92August 2, 2024 | bovnews.comBMeihua International Medical Technologies Facilitates World's Second* 5G Remote Robot-Assisted LobectomyJuly 31, 2024 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAMIX, MHUA, LYRA, and INBS Company DescriptionsAutonomix Medical NASDAQ:AMIX$1.42 -0.01 (-0.70%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$1.38 -0.04 (-2.61%) As of 04:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.Intelligent Bio Solutions NASDAQ:INBS$1.90 +0.17 (+9.83%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$1.92 +0.02 (+1.05%) As of 07/15/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Lyra Therapeutics NASDAQ:LYRA$8.48 -0.23 (-2.64%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$8.45 -0.03 (-0.35%) As of 07/15/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.Meihua International Medical Technologies NASDAQ:MHUA$0.44 -0.01 (-1.55%) Closing price 07/15/2025 03:59 PM EasternExtended Trading$0.42 -0.02 (-3.68%) As of 07/15/2025 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Tesla: 2 Plays Ahead of Next Week's Earnings Report New Catalyst Sends Joby Stock to 52-Week Highs Palantir Gets Price Hike From Wedbush Amid High Valuation Fastenal Surges After Earnings Beat, Tariff Risks Loom Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
